4.0 Article

Apheresis practice patterns in the United States of America: Analysis of a market claims database

期刊

JOURNAL OF CLINICAL APHERESIS
卷 36, 期 5, 页码 750-758

出版社

WILEY
DOI: 10.1002/jca.21926

关键词

database; International Classification of Diseases; Ninth version; plasma exchange; red blood cell exchange

资金

  1. Masonic Cancer Research Fund
  2. National Center for Advancing Translational Sciences [UL1TR002494]
  3. University of Minnesota, Department of Laboratory Medicine and Pathology

向作者/读者索取更多资源

This study analyzed the patterns and situations of apheresis procedures using health insurance claims data from large employers and health plans across the United States. A wide variety of diagnoses were treated through apheresis, but some procedure codes may not accurately reflect the nature of the procedures. The study highlights the need for direct measurement of apheresis procedures for future research studies.
Introduction Indications for apheresis procedures are expanding; however, the evidence for many is low quality. A better understanding of apheresis patterns in the United States is needed to better plan prospective research studies. Methods Data from January 1, 2013, to September 30, 2015, were analyzed from the IBM MarketScan Research Databases of de-identified health insurance claims data of several million enrollees at all levels of care from large employers and health plans across the United States. Apheresis procedures were identified by International Classification of Diseases, Ninth version (ICD-9) and Current Procedure Terminology (CPT) codes. Results Combining inpatients and outpatients, 18 706 patients underwent 70 247 procedures. The patients were 52.7% female, 5.1% <18 years, and 55.9% inpatient, while the procedures were 49.5% female, 5.7% <18 years, and 19.8% inpatient. For each apheresis modality, the percent of patients treated and procedures performed, respectively, are plasmapheresis 36.4% and 42.5%, autologous harvest of stem cells 22.8% and 10.7%, plateletpheresis 11.1% and 3.5%, allogeneic harvest of stem cells 8.2% and 2.5%, photopheresis 5.4% and 24.4%, erythrocytapheresis 3.8% and 4.7%, leukopheresis 2.0% and 0.7%, immunoadsorption 1.4% and 0.4%, extracorporeal selective adsorption/filtration and plasma reinfusion 1.0% and 3.6%, and other 21.6% and 6.9%. A wide variety of diagnoses were treated; however, analysis of the diagnoses suggests the procedure codes may not always reflect an apheresis procedure. Conclusion This study describes the landscape of apheresis in the United States, but may overestimate some procedures based on linked diagnosis codes. Direct measures of apheresis procedures are needed to plan future research studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据